BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961


SEARCH JOBS




Industry
Biotechnology






 Company News
Keryx Biopharmaceuticals (KERX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014 8:14:35 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Auryxia (Ferric Citrate) Covering Orally Administrable Forms 12/4/2014 4:37:33 PM
Keryx Biopharmaceuticals (KERX) Release: Auryxia (Ferric Citrate) Phase 2 Data Published In The American Journal Of Kidney Disease 12/2/2014 1:34:56 PM
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014 9:18:53 AM
Keryx Biopharmaceuticals (KERX) Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study 11/17/2014 10:32:03 AM
Keryx Biopharmaceuticals (KERX) To Present At The Stifel 2014 Healthcare Conference 11/14/2014 10:16:34 AM
Keryx Biopharmaceuticals (KERX) Announces Third Quarter And Nine Month 2014 Financial Results 11/6/2014 10:53:07 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Third Quarter 2014 Financial Results 10/30/2014 8:37:08 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms 10/1/2014 8:55:44 AM
Keryx Biopharmaceuticals (KERX) Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease 9/29/2014 8:57:11 AM
12345678910...